Guo‐Hao Huang

623 total citations
34 papers, 455 citations indexed

About

Guo‐Hao Huang is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Guo‐Hao Huang has authored 34 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Genetics and 12 papers in Cancer Research. Recurrent topics in Guo‐Hao Huang's work include Glioma Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (4 papers). Guo‐Hao Huang is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (4 papers). Guo‐Hao Huang collaborates with scholars based in China, United Kingdom and United States. Guo‐Hao Huang's co-authors include Shengqing Lv, Xiang Yan, Qingfu Xu, Xuhua Duan, Ningning Li, Jianzhuang Ren, Xinwei Han, Xiu‐Wu Bian, Lin Yang and Mengfan Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Experimental Cell Research and Cancer Letters.

In The Last Decade

Guo‐Hao Huang

31 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guo‐Hao Huang China 12 207 127 123 84 80 34 455
Praveen Medabalmi United States 6 113 0.5× 245 1.9× 106 0.9× 76 0.9× 68 0.8× 10 394
Xingen Zhu China 12 189 0.9× 45 0.4× 100 0.8× 89 1.1× 64 0.8× 37 389
Nobuyasu Takahashi Japan 10 263 1.3× 38 0.3× 50 0.4× 69 0.8× 148 1.9× 30 591
Zehava Vadasz Israel 5 262 1.3× 72 0.6× 38 0.3× 46 0.5× 52 0.7× 8 437
Luigi Tomao Italy 11 177 0.9× 66 0.5× 152 1.2× 74 0.9× 44 0.6× 22 398
Shuo Xu China 11 268 1.3× 97 0.8× 232 1.9× 75 0.9× 50 0.6× 21 575
Ruiyun Xu China 15 334 1.6× 98 0.8× 187 1.5× 82 1.0× 191 2.4× 36 745
Sweta Sudhir United States 8 134 0.6× 64 0.5× 67 0.5× 48 0.6× 58 0.7× 16 373
Silke Götze Germany 12 403 1.9× 83 0.7× 132 1.1× 37 0.4× 217 2.7× 19 731
Laura Parma Netherlands 8 214 1.0× 60 0.5× 133 1.1× 61 0.7× 51 0.6× 10 423

Countries citing papers authored by Guo‐Hao Huang

Since Specialization
Citations

This map shows the geographic impact of Guo‐Hao Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo‐Hao Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo‐Hao Huang more than expected).

Fields of papers citing papers by Guo‐Hao Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guo‐Hao Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo‐Hao Huang. The network helps show where Guo‐Hao Huang may publish in the future.

Co-authorship network of co-authors of Guo‐Hao Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Guo‐Hao Huang. A scholar is included among the top collaborators of Guo‐Hao Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo‐Hao Huang. Guo‐Hao Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Guo‐Hao, et al.. (2024). Single-cell analysis of a progressive Rosai–Dorfman disease affecting the cerebral parenchyma: a case report. Acta Neuropathologica Communications. 12(1). 78–78.
3.
Wang, Tingting, Guo‐Hao Huang, Yao Li, et al.. (2023). HOXD‐AS2‐STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma. CNS Neuroscience & Therapeutics. 29(11). 3430–3445. 8 indexed citations
4.
Wang, Tingting, et al.. (2023). Advances in extracellular vesicle-based combination therapies for spinal cord injury. Neural Regeneration Research. 19(2). 369–374. 13 indexed citations
5.
Huang, Guo‐Hao, Guolong Liu, Xiang Yan, et al.. (2023). Case Report: An Intracranial Aspergillus Infection with Cyst Formation. Brain Sciences. 13(2). 239–239.
6.
Liu, Jing, Weiwei Huang, Guo‐Hao Huang, et al.. (2023). Case report: Two case reports of cryptogenic brain abscess caused by Fusobacterium nucleatum and literature review. Frontiers in Neuroscience. 17. 1248493–1248493. 1 indexed citations
7.
Yang, Wei, Xiang Yan, Pengfei Wu, et al.. (2021). Presenilin1 inhibits glioblastoma cell invasiveness via promoting Sortilin cleavage. Cell Communication and Signaling. 19(1). 112–112. 6 indexed citations
8.
Duan, Xuhua, Xinwei Han, Jianzhuang Ren, et al.. (2020). Combined use of microwave ablation and cell immunotherapy induces nonspecific immunity of hepatocellular carcinoma model mice. Cell Cycle. 19(24). 3595–3607. 40 indexed citations
11.
Yang, Lin, Juxiang Chen, Qingrui Li, et al.. (2019). Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis. Cancer Communications. 39(1). 81–81. 68 indexed citations
12.
Lv, Shengqing, et al.. (2018). Intraoperative fluorescence-guided resection of high-grade glioma: A systematic review. SHILAP Revista de lepidopterología. 1(6). 189–189. 2 indexed citations
13.
Huang, Guo‐Hao, Hong Shan, Dan Li, Bin Zhou, & Pengfei Pang. (2017). MiR‐199a‐5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Cell Biochemistry and Function. 35(2). 98–104. 25 indexed citations
14.
Ma, Zhixiong, Guo‐Hao Huang, Qingfu Xu, et al.. (2016). Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment. Experimental Cell Research. 343(2). 148–158. 33 indexed citations
15.
Zhu, Xiaopeng, Kejie Mou, Qingfu Xu, et al.. (2015). Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades. Oncology Reports. 34(1). 318–324. 9 indexed citations
16.
Li, Teng‐Fei, Guo‐Hao Huang, Zhen Li, et al.. (2015). Percutaneous Transhepatic Cholangiography and Intraductal Radiofrequency Ablation Combined with Biliary Stent Placement for Malignant Biliary Obstruction. Journal of Vascular and Interventional Radiology. 26(5). 715–721. 31 indexed citations
17.
Duan, Xuhua, Kai Zhang, Xinwei Han, et al.. (2014). Comparison of Percutaneous Transhepatic Variceal Embolization (PTVE) Followed by Partial Splenic Embolization versus PTVE Alone for the Treatment of Acute Esophagogastric Variceal Massive Hemorrhage. Journal of Vascular and Interventional Radiology. 25(12). 1858–1865. 20 indexed citations
18.
Li, Teng‐Fei, Xuhua Duan, Zhen Li, et al.. (2014). Endovascular embolization for managing anastomotic bleeding after stapled digestive tract anastomosis. Acta Radiologica. 56(11). 1368–1372. 5 indexed citations
19.
Ren, Jianzhuang, Guo‐Hao Huang, Peng‐Xu Ding, et al.. (2013). Outcomes of Thrombolysis With and Without Predilation of the Inferior Vena Cava (IVC) in Patients With Budd–Chiari Syndrome With Old IVC Thrombosis. Vascular and Endovascular Surgery. 47(3). 232–238. 10 indexed citations
20.
Ren, Jianzhuang, Kai Zhang, Guo‐Hao Huang, et al.. (2013). Assessment of 64-row computed tomographic angiography for diagnosis and pretreatment planning in pulmonary sequestration. La radiologia medica. 119(1). 27–32. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026